Evidence map›Paper›PMID 32280580›Full record

ArticleChemistryOpen2020

SilverSil: A New Class of Antibacterial Materials of Broad Scope.

Keren Trabelsi, Rosaria Ciriminna, Yael Albo, Mario Pagliaro

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemistryOpen, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Keren TrabelsiDepartment Chemical Engineering, Materials and Biotechnology The Center for Radical Reactions Ariel University Jerusalem Israel.
Rosaria CiriminnaIstituto per lo Studio dei Materiali Nanostrutturati, CNR via U. La Malfa 153 90146 Palermo Italy.
Yael AlboDepartment Chemical Engineering, Materials and Biotechnology The Center for Radical Reactions Ariel University Jerusalem Israel.
Mario PagliaroIstituto per lo Studio dei Materiali Nanostrutturati, CNR via U. La Malfa 153 90146 Palermo Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consisting of organically modified silica (ORMOSIL) physically doped with Ag nanoparticles, the SilverSil new class of antibacterial materials of broad scope reported herein shows remarkably high and stable activity against representative Gram-positive and Gram-negative bacteria. The low cost, ease of application and excellent health and environmental profile of SilverSil hybrid glassy coatings open the route to their widespread utilization across domestic, hospital, school, industrial and commercial environments and in consumer products.

Indexed as

Anti-Bacterial AgentsDrug DevelopmentEscherichia coliMetal NanoparticlesMicrobial Sensitivity TestsPorositySilicon DioxideSilverStaphylococcus aureusSurface PropertiesAnti-Bacterial AgentsSilicon DioxideSilverAntibacterial activityEscherichia coliORMOSILSilverStaphylococcus aureus

Identifiers

PMID32280580
PMCPMC7143115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.